Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Ewing's sarcoma and related subtypes of primitive neuroectodermal tumours share a recurrent and specific t(11;22) (q24;q12) chromosome translocation, the breakpoints of which have recently been cloned. Phylogenetically conserved restriction fragments in the vicinity of EWSR1 and EWSR2, the genomic regions where the breakpoints of chromosome 22 and chromosome 11 are, respectively, have allowed identification of transcribed sequences from these regions and has indicated that a hybrid transcript might be generated by the translocation. Here we use these fragments to screen human complementary DNA libraries to show that the translocation alters the open reading frame of an expressed gene on chromosome 22 gene by substituting a sequence encoding a putative RNA-binding domain for that of the DNA-binding domain of the human homologue of murine Fli-1.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ewing’s sarcoma, a common pediatric cancer, is invariably associated with ETS gene translocations (182) that result in a fusion oncogene consisting of the 5′ end of EWS and the 3′ end of FLI1, or less frequently ERG, ETV1, ETV4, or FEV (Figure 1a) (183, 184).”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [183]
Citations
Cites
Kozak, M. (1986) · Cell · doi:10.1016/0092-8674(86)90762-2 · Cited by 4,741
Transcriptional Regulation in Mammalian Cells by Sequence-Specific DNA Binding Proteins
Mitchell, P. J., & Tjian, R. (1989) · Science · doi:10.1126/science.2667136 · Cited by 3,114
RNA recognition: towards identifying determinants of specificity
Kenan, D. J., Query, C. C., & Keene, J. D. (1991) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(91)90088-d · Cited by 730
RNA-binding proteins as developmental regulators.
Bandziulis, R. J., Swanson, M. S., & Dreyfuss, G. (1989) · Genes & Development · doi:10.1101/gad.3.4.431 · Cited by 644
Turc-Carel, C., Aurias, A., Mugneret, F., Lizard, S., Sidaner, I., Volk, C., Thiery, J. P., Olschwang, S., Philip, I., Berger, M. P., et al. (1988) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(88)90285-3 · Cited by 466
Self-citationBen-David, Y., Giddens, E. B., Letwin, K., & Bernstein, A. (1991) · Genes & Development · doi:10.1101/gad.5.6.908 · Cited by 403
Chromosome Translocation in Peripheral Neuroepithelioma
Whang-Peng, J., Triche, T. J., Knutsen, T., Miser, J., Douglass, E. C., & Israel, M. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198408303110907 · Cited by 399
Chromosomal Translocations in Ewing's Sarcoma
(1983) · New England Journal of Medicine · doi:10.1056/nejm198308253090817 · Cited by 330
Corden, J. L. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90236-5 · Cited by 327
Turc-Carel, C., Philip, I., Berger, M.-P., Philip, T., & Lenoir, G. M. (1984) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(84)90002-5 · Cited by 291
Research works printed but not linked: 8
- Aurias, A., Rimbaut, C., Buffe, C., Dubousset, J. & Mazabraud, A. N. Engl. J. Med. 309, 496–497 (1983).
- Turc-Carel, C., Philip, I., Berge, R. M. P., Philip, T. & Lenoir, G. M. N. Engl. J. Med. 309, 497–498 (1983).
- De Chadarevian, J. P., Vekemans, M. & Seemayer, T. A. N. Engl. J. Med. 311, 1702–1703 (1984).
- Cavazzana, A. O. et al. Adv. Neuroblastoma Res. 2, 463–473 (1988).
- Zucman, J. et al. Genes Chrom. Cancer (in the press).
- Douglass, E. C., Valentine, M., Green, A. A., Hayes, F. A. & Thompson, E. I. J. natn. Cancer Inst. 77, 1211–1213 (1986).
- Watson, D. K., Ascione, R. & Papas, T. S. Crit. Rev. Oncogenesis 1, 409–436 (1990).
- Rouleau, G. A. et al. Am. J. hum. Genet. 46, 323–328 (1990).
Cited by
Items 201–300 of 1,002
RNA-Binding Proteins in Amyotrophic Lateral Sclerosis.
Zhao, M., Kim, J. R., van Bruggen, R., & Park, J. (2018) · PubMed · doi:10.14348/molcells.2018.0243 · Cited by 128
Yeung, C., Gibson, A. E., Issaq, S. H., Oshima, N., Baumgart, J. T., Edessa, L. D., Rai, G., Urban, D. J., Johnson, M. S., Benavides, G. A., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0217 · Cited by 131
“9 LDHA is regulated by EWS-FLI1 EWS is characterized by a reciprocal translocation between chromosomes 11 and 22, resulting in the oncogenic transcription factor EWS-FLI1, which acts as the primary driver of the disease (17, 18).”
BackgroundIdentification of p21 as a Direct Target of EWS-Fli1 Oncogenic Fusion Protein
Nakatani, F., Tanaka, K., Sakimura, R., Matsumoto, Y., Matsunobu, T., Li, X., Hanada, M., Okada, T., & Iwamoto, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211470200 · Cited by 155
Mammalian orthologues of a yeast regulator of nonsense transcript stability.
Perlick, H. A., Medghalchi, S. M., Spencer, F. A., Kendzior, R. J., & Dietz, H. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10928 · Cited by 137
Ets transcription factors and human disease
Dittmer, J., & Nordheim, A. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00039-5 · Cited by 185
de Alava, E., Ladanyi, M., Rosaí, J., & Gerald, W. L. (1995) · Europe PMC (PubMed Central) · Cited by 136
Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas.
Komuro, H., Hayashi, Y., Kawamura, M., Hayashi, K., Kaneko, Y., Kamoshita, S., Hanada, R., Yamamoto, K., Hongo, T., & Yamada, M. (1993) · PubMed · Cited by 135
The EWS/FLI1 oncogenic transcription factor deregulates GLI1
Zwerner, J. P., Joo, J., Warner, K., Christensen, L., Hu‐Lieskovan, S., Triche, T. J., & May, W. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210991 · Cited by 135
“Nearly all cases feature a class of chromosomal translocations that fuse the DNA-binding domain of an ets transcription factor to the N-terminal region of the EWS gene (Delattre et al., 1992).”
BackgroundOncoprotein EWS-FLI1 Activity Is Enhanced by RNA Helicase A
Toretsky, J. A., Erkızan, V., Levenson, A. E., Abaan, O. D., Parvin, J. D., Cripe, T. P., Rice, A. M., Lee, S. B., & Üren, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3293 · Cited by 145
“retains the conserved Ets DNA binding domain from FLI1 in the fusion protein (15, 38).”
Desmoplastic Small Round Cell Tumors of the Paratesticular Region
Cummings, O. W., Ulbright, T. M., Young, R. H., Tos, A. P. D., Fletcher, C. D. �., & Hull, M. T. (1997) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199702000-00013 · Cited by 134
Cohen‐Gogo, S., Cellier, C., Coindre, J., Mosseri, V., Pierron, G., Guillemet, C., Italiano, A., Brugières, L., Orbach, D. H., Laurence, V., et al. (2014) · Pediatric Blood & Cancer · doi:10.1002/pbc.25210 · Cited by 133
“Ewing sarcoma (ES), one of the most predominant sarcomas in this age group, is most often genetically characterized by fusions between genes in the FET and ETS families [2,3].”
BackgroundSelf-citationThe Splicing Factor U1C Represses EWS/FLI-mediated Transactivation
Knoop, L. L., & Baker, S. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001661200 · Cited by 130
The role of Fli-1 in normal cell function and malignant transformation
Truong, A. H. L., & Ben‐David, Y. (2000) · Oncogene · doi:10.1038/sj.onc.1204042 · Cited by 155
“Indeed, this pediatric disease is characterized by a genetic rearrangement in which Fli-1 becomes juxtaposed 3' to the EWS gene (Delattre et al., 1992).”
BackgroundThe FLI-1 and chimeric EWS-FLI-1 oncoproteins display similar DNA binding specificities.
Mao, X., Miesfeldt, S., Yang, H., Leiden, J. M., & Thompson, C. B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32437-7 · Cited by 132
West, D. C., Grier, H. E., Swallow, M. M., Demetri, G. D., Granowetter, L., & Sklar, J. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.2.583 · Cited by 133
The ets Family Member Tel Binds to the Fli-1 Oncoprotein and Inhibits Its Transcriptional Activity
Kwiatkowski, B. A., Bastian, L. S., Bauer, T. R., Tsai, S., Zielinska-Kwiatkowska, A. G., & Hickstein, D. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.28.17525 · Cited by 131
Ecteinascidin 743 Interferes with the Activity of EWS-FLI1 in Ewing Sarcoma Cells
Grohar, P. J., Griffin, L. B., Yeung, C. L., Chen, Q.-R., Pommier, Y. G., Khanna, C., Khan, J. I., & Helman, L. J. (2011) · Neoplasia · doi:10.1593/neo.101202 · Cited by 130
Rodrı́guez, E., Sreekantaiah, C., Gerald, W. L., Reuter, V. E., Motzer, R. J., & Chaganti, R. S. K. (1993) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(93)90105-u · Cited by 130
TLS-ERG Leukemia Fusion Protein Inhibits RNA Splicing Mediated by Serine-Arginine Proteins
Yang, L., Embree, L. J., & Hickstein, D. D. (2000) · Molecular and Cellular Biology · doi:10.1128/.20.10.3345-3354.2000 · Cited by 129
“TLS belongs to a family of closely related proteins, including Ewing’s sarcoma protein, EWS ( 13 ), and TATA-binding protein-associated factor, TAFII68 (3).”
BackgroundMao, S., Frank, R. C., Zhang, J., Miyazaki, Y., & Nimer, S. D. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3635 · Cited by 129
“And like AML1, ETS proteins are frequently targeted by chromosomal translocations in human cancer (generating fusion proteins such as TEL-AML1, TEL-ABL, TELPDGFbR, EWS-FLI-1, FLI-EWS, EWS-ERG, ERG-EWS, EWS-ETV1, and ETV1-EWS [10, 14, 15, 18, 37, 42]).”
BackgroundFuchs, B., Inwards, C. Y., & Janknecht, R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0038 · Cited by 139
“With the detection of the first Ewing’s sarcoma-associated fusion protein EWS-Fli1 more than a decade ago (1), great hope was nourished that this finding may lead to a simple mechanistic explanation of the pathogenesis of this tumor.”
PDGF-C is an EWS/FLI induced transforming growth factor in Ewing family tumors
Zwerner, J. P., & May, W. A. (2001) · Oncogene · doi:10.1038/sj.onc.1204133 · Cited by 141
“Virtually all EFT's are associated with oncogenic chimeric proteins which fuse amino-terminal EWS with the DNA binding moiety of an ETS transcription factor (FLI-1 in 90% of cases) (Delattre et al., 1992; May and Denny, 1997).”
BackgroundEZH2 Inhibition in Ewing Sarcoma Upregulates GD2 Expression for Targeting with Gene-Modified T Cells
Kailayangiri, S., Altvater, B., Lesch, S., Balbach, S. T., Göttlich, C., Kühnemundt, J., Mikesch, J., Schelhaas, S., Jamitzky, S., Meltzer, J., et al. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.02.014 · Cited by 131
“We seek to develop cellular therapies to treat Ewing sarcoma (EwS), an aggressive solid mesenchymal malignancy arising in bone and soft tissues.7 EwS is characterized by a specific chromosomal translocation, most commonly of chromosomes 22 and 11 (t(11,22)(q24;12)), resulting in the aberrant chimeric transcription fac…”
BackgroundPollack, S. M., Jungbluth, A. A., Hoch, B. L., Farrar, E. A., Bleakley, M., Schneider, D. J., Loggers, E. T., Rodler, E., Eary, J. F., Conrad, III, et al. (2012) · Cancer · doi:10.1002/cncr.27446 · Cited by 125
Fukuma, M., Okita, H., Hata, J.-I., & Umezawa, A. (2003) · Oncogene · doi:10.1038/sj.onc.1206055 · Cited by 126
“This chromosomal translocation results in the fusion of the 50 segment of the EWS gene on chromosome 22 with the 30 segment of the Fli-1 gene on chromosome 11 (Delattre et al., 1992).”
BackgroundA Multiplex Real-Time PCR Assay for the Detection of Gene Fusions Observed in Solid Tumors
Peter, M., Gilbert, E., & Delattre, O. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780299 · Cited by 125
Self-citationHerrero‐Martín, D., Osuna, D., Ordóñez, J. L., Sevillano, V., Martins, A. S., Mackintosh, C., Campos, M., Madoz‐Gúrpide, J., Otero-Motta, A. P., Caballero, G., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605104 · Cited by 124
“Ewing sarcoma is characterised by the presence of chimeric proteins joining the NH2-terminal domain of the RNA-binding protein EWS with the DNA-binding portion of an ETS transcription factor, FLI1, in 90% of the cases (Delattre et al, 1992; Sorensen et al, 1994; May et al, 1997).”
BackgroundAnalysis of the ERK-Stimulated ETS Transcription Factor ER81
Janknecht, R. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1550 · Cited by 124
“Similarly, the carboxy-terminal regions of Fli-1 and ERG, also including their ETS domains, are fused to the EWS protein in 85 or 10% of all Ewing’s sarcomas by the chromosomal translocation t(11;22)(q24;q12) or t(21;22)(q22;q12), respectively (11, 40, 46).”
BackgroundThe EWS/FLI Oncogene Drives Changes in Cellular Morphology, Adhesion, and Migration in Ewing Sarcoma
Chaturvedi, A. P., Hoffman, L. M., Welm, A. L., Lessnick, S. L., & Beckerle, M. C. (2012) · Genes & Cancer · doi:10.1177/1947601912457024 · Cited by 127
“The EWS/FLI fusion protein links the amino terminus of EWS, a strong transcriptional activator, and the carboxy terminus of FLI1, a DNA-binding protein from the ETS family of transcription factors.(31,34) EWS/FLI acts as a transcriptional regulator to modulate hundreds to thousands of genes expression, and ongoing EWS…”
BackgroundSancéau, J., Truchet, S., & Bauvois, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304300200 · Cited by 132
Identification of Target Genes of the p16INK4A-pRB-E2F Pathway
Vernell, R., Helin, K., & Müller, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304930200 · Cited by 123
Advances in Ewing's Sarcoma Research: Where Are We Now and What Lies Ahead?
Ordóñez, J. L., Osuna, D., Herrero, D., de Álava, E., & Madoz‐Gúrpide, J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4041 · Cited by 122
Recurrent gains of 1q, 8 and 12 in the Ewing family of tumours by comparative genomic hybridization
Armengol, G., Tarkkanen, M., Virolainen, M. J., Forus, A., Valle, J., Böhling, T., Asko-Seljavaara, S. L., BLOMQVIST, C. P., Elomaa, I., Karaharju, E., et al. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.242 · Cited by 122
Deletions on chromosome 22 in sporadic meningioma
Ruttledge, M. H., Xie, Y., Han, F., Peyrard, M., Collins, V. P., Nordenskjöld, M., & Dumanski, J. P. (1994) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870100207 · Cited by 122
Pathology of Ewing’s sarcoma/PNET: Current opinion and emerging concepts
Desai, S. S., & Jambhekar, N. A. (2010) · Indian Journal of Orthopaedics · doi:10.4103/0019-5413.69304 · Cited by 125
“In another 10–15% of cases, the translocation t(21;12)(22;12) resulting in EWS-ERG (Ets-related gene) fusion13 is seen.”
BackgroundThe Ewing's sarcoma gene product functions as a transcriptional activator.
Rossow, K. L., & Janknecht, R. (2001) · PubMed · Cited by 144
Patel, M., Simon, J. M., Iglesia, M. D., Wu, S. B., McFadden, A. W., Lieb, J. D., & Davis, I. J. (2012) · Genome Research · doi:10.1101/gr.125666.111 · Cited by 114
“Ewing Sarcoma, a bone tumor of children and young adults, is characterized by translocations that fuse a member of the TET family to a member of the ETS transcription factor family (Delattre et al. 1992; Sorensen et al. 1994; Jeon et al. 1995).”
BackgroundInfluentialKruse, E. A., Loughran, S. J., Baldwin, T. M., Josefsson, E. C., Ellis, S., Watson, D. K., Nurden, P., Metcalf, D., Hilton, D. J., Alexander, W. S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906556106 · Cited by 110
“Fli-1 is mutated in a number of cancers, including Ewing’s sarcoma and erythroleukemia (2, 3).”
BackgroundMöller, E., Stenman, G., Mandahl, N., Hamberg, H., Mölne, L., van den Oord, J., Brosjö, O., Mertens, F., & Panagopoulos, I. (2008) · The Journal of Pathology · doi:10.1002/path.2327 · Cited by 129
“The EWSR1 gene at 22q12 was originally identified in the Ewing sarcoma family of tumours as part of the fusion gene EWSR1–FLI1, created by the translocation t(11;22)(q24;q12) [1].”
BackgroundSancéau, J., Hiscott, J. B., Delattre, O., & Wietzerbin, J. (2000) · Oncogene · doi:10.1038/sj.onc.1203670 · Cited by 135
“…chromosome, of the 5' half end of a resident EWS gene (Ewing's sarcoma gene) of unknown function, with the 3' portion of the chromosome 11-derived Fli-1 gene (Friend Leukemia Integrator-1 gene) carrying the Ets domain with a speci®c DNA-binding motif (Delattre et al., 1992; Bailly et al., 1993).”
BackgroundSelf-citationThe Ets transcription factors of the PEA3 group: Transcriptional regulators in metastasis
de Launoit, Y., Baert, J., Chotteau‐Lelièvre, A., Monté, D., Coutte, L., Mauën, S., Firlej, V., Degerny, C., & Verreman, K. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.02.002 · Cited by 129
IGF1 Is a Common Target Gene of Ewing's Sarcoma Fusion Proteins in Mesenchymal Progenitor Cells
Cironi, L., Riggi, N., Provero, P., Wolf, N., Suvà, M.-L., Suvà, D., Kindler, V., & Stamenkovic, I. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002634 · Cited by 118
“The most common chromosomal translocation, associated with 85% of ESFTs is t(22;11)(q24;q12 ), which generates the EWS-FLI-1 fusion [3].”
BackgroundFrequent loss of heterozygosity at the TEL gene locus in acute lymphoblastic leukemia of childhood
Stegmaier, K., Pendse, S., Barker, G., Bray-Ward, P., Ward, D., Montgomery, K., Krauter, K., Reynolds, C., Sklar, J., & Donnelly, M. (1995) · Blood · doi:10.1182/blood.v86.1.38.bloodjournal86138 · Cited by 119
Lopez, M., Oettgen, P., Akbarali, Y., Dendorfer, U., & Libermann, T. A. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.5.3292 · Cited by 120
Oncogenic ETS fusions deregulate E2F3 target genes in Ewing sarcoma and prostate cancer
Bilke, S., Schwentner, R., Yang, F., Kauer, M. O., Jug, G., Walker, R. L., Davis, S. R., Zhu, Y. J., Pineda, M. A., Meltzer, P. S., et al. (2013) · Genome Research · doi:10.1101/gr.151340.112 · Cited by 122
“EWSR1/FLI1 represented the first example of an oncogenic ETS transcription factor rearrangement in human solid tumors (Delattre et al. 1992), and there is ample functional evidence for its decisive role in malignant transformation and tumorigenesis (Kovar 2010).”
BackgroundSelf-citationGiacomini, C. P., Sun, S., Varma, S., Shain, A. H., Giacomini, M. M., Balagtas, J. M. S., Sweeney, R. T., Lai, E., Fitz, C. D. V., Forster, A. D., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003464 · Cited by 123
Protein phase separation and its role in tumorigenesis
Jiang, S., Fagman, J. B., Chen, C., Alberti, S., & Liu, B. (2020) · eLife · doi:10.7554/elife.60264 · Cited by 126
The hybrid PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma transforms fibroblasts in culture.
Scheidler, S., Fredericks, W. J., Rauscher, F. J., Barr, F. G., & Vogt, P. K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9805 · Cited by 130
TRIM8 modulates the EWS/FLI oncoprotein to promote survival in Ewing sarcoma
Seong, B. K. A., Dharia, N. V., Lin, S., Donovan, K. A., Chong, S., Robichaud, A., Conway, A., Hamze, A., Ross, L., Alexe, G., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.07.003 · Cited by 113
“Ewing sarcoma is characterized by a chromosomal rearrangement that fuses the transactivation domain of EWS with the DNA binding domain of ETS transcription factors, most commonly FLI1, leading to expression of the EWS/FLI fusion oncoprotein (Delattre et al., 1992).”
BackgroundGranada, C. N. P., Zhang, L., Chen, H., Sung, Y., Agaram, N. P., Jungbluth, A. A., & Antonescu, C. R. (2014) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22215 · Cited by 116
“EWSR1, FUS (a.k.a. TLS), and TAF15 belong to the TET family of transcription factors, sharing an RNA binding domain (Delattre et al., 1992; Stolow and Haynes, 1995; Bertolotti et al., 1996; Riggi et al., 2007).”
BackgroundSjögren, H., Wedell, B., Meis‐Kindblom, J. M., Kindblom, L., Stenman, G., & Kindblom, J. M. (2000) · PubMed · Cited by 123
Characterization of a Family of RanBP2-Type Zinc Fingers that Can Recognize Single-Stranded RNA
Nguyen, C. D., Mansfield, R. E., Leung, W., Vaz, P. M., Loughlin, F. E., Grant, R. P., & Mackay, J. P. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.12.041 · Cited by 130
Mackintosh, C., Ordóñez, J. L., García-Domínguez, D. J., Sevillano, V., Llombart‐Bosch, A., Szuhai, K., Scotlandi, K., Alberghini, M., Sciot, R., Sinnaeve, F., et al. (2011) · Oncogene · doi:10.1038/onc.2011.317 · Cited by 124
“…presence of specific balanced chromosomal translocations, which give rise to oncogenic chimeric proteins (EWS-ETS), the most common being EWS-FLI1 as a consequence of the t(11;22)(q24;q12) translocation (Aurias et al., 1984; Turc-Carel et al., 1984; Whang-Peng et al., 1984; Delattre et al., 1992).”
BackgroundMultifunctional zinc finger proteins in development and disease
Ladomery, M., & Dellaire, G. (2002) · Annals of Human Genetics · doi:10.1046/j.1469-1809.2002.00121.x · Cited by 115
“…central nervous system during embryo- genesis (Stolow & Haynes, 1995) ; EWS, cloned from a translocation breakpoint associated with Ewing’s Sarcoma (Delattre et al. 1992) ; TLS, also known as FUS, cloned from a breakpoint associated with myxoid liposarcoma (Crozat et al. 1993) ; and TAFII68, a…”
BackgroundTargeting Intrinsically Disordered Transcription Factors: Changing the Paradigm
Tsafou, K., Tiwari, P. B., Forman-Kay, J. D., Metallo, S. J., & Toretsky, J. A. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.04.008 · Cited by 112
Nanopore sequencing of single-cell transcriptomes with scCOLOR-seq
Philpott, M., Watson, J., Thakurta, A., Brown, T., Brown, T., Oppermann, U. C. T., & Cribbs, A. P. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-00965-w · Cited by 130
Palacio, M., & Taatjes, D. J. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167216 · Cited by 122
Ewing tumor fusion proteins block the differentiation of pluripotent marrow stromal cells.
Torchia, E. C., Jaishankar, S., & Baker, S. J. (2003) · PubMed · Cited by 130
Panagopoulos, I., Mertens, F., Isaksson, M., Domanski, H. A., Brosjö, O., Heim, S., Bjerkehagen, B., Sciot, R., Cin, P. D., Fletcher, J. A., et al. (2002) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10127 · Cited by 114
“The EWS primers were based on the EWS cDNA sequence (accession number X66899) (Delattre et al., 1992), RBP56 primers were based on the RBP56 cDNA sequence (accession numbers X98893, U51334) (Bertolotti et al., 1996; Morohoshi et al., 1996), and CHN primers on the reported CHN cDNA sequence (accession numbers S81243, X…”
BackgroundMethodInfluentialSjögren, H., Meis‐Kindblom, J. M., Örndal, C., Bergh, P., Ptaszyński, K., Åman, P., Kindblom, L., & Stenman, G. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63875-8 · Cited by 118
Powers, C. A., Mathur, M., Raaka, B. M., Ron, D., & Samuels, H. H. (1998) · Molecular Endocrinology · doi:10.1210/mend.12.1.0043 · Cited by 110
Prognostic impact of chromosomal aberrations in Ewing tumours
Hattinger, C. M., Pötschger, U., Tarkkanen, M., Squire, J. A., Zieleńska, M., Kiuru‐Kuhlefelt, S., Kager, L., Thorner, P. S., Knuutila, S., Niggli, F. K., et al. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600332 · Cited by 119
“The t(11;22)(q24;q12) that is present in 85 – 90% of ETs (Mitelman et al, 2001) generates a chimeric fusion transcript between the EWS (22q12) and FLI1 (11q24) genes (Delattre et al, 1992; Zucman et al, 1992).”
BackgroundThorner, P. S., Squire, J. A., Chilton‐MacNeill, S., Marrano, P. M., Bayani, J., Malkin, D. M., Greenberg, M., Lorenzana, A., & Zieleńska, M. (1996) · Europe PMC (PubMed Central) · Cited by 125
Stenman, G., Andersson, H. C., Mandahl, N., Meis‐Kindblom, J. M., & Kindblom, L. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910620407 · Cited by 112
Role of cervical lymph nodes in autoimmune encephalomyelitis in the Lewis rat
Phillips, M. J., Needham, M., & Weller, R. O. (1997) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199708)182:4<457::aid-path870>3.0.co;2-y · Cited by 117
Divergent Ewing's sarcoma EWS/ETS fusions confer a common tumorigenic phenotype on NIH3T3 cells
Thompson, A. D., Teitell, M. A., Arvand, A., & Denny, C. T. (1999) · Oncogene · doi:10.1038/sj.onc.1202928 · Cited by 130
“In most Ewing's sarcomas, EWS is fused to the carboxyl terminus of either FLI1 or ERG, two very closely related ETS proteins (Delattre et al., 1992, 1994; Sorensen et al., 1994; Giovannini et al., 1994).”
BackgroundRegulation of Gene Expression by Multiple Forms of TFIID and Other Novel TAFII-Containing Complexes
Bell, B., & Tora, L. (1999) · Experimental Cell Research · doi:10.1006/excr.1998.4294 · Cited by 113
Minas, T. Z., Surdez, D., Javaheri, T., Tanaka, M., Howarth, M., Kang, H., Han, J. J., Han, Z., Sax, B., Kream, B. E., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9388 · Cited by 116
“ES cases show a balanced chromosomal translocation [4] that joins the EWS gene (EWing Sarcoma) located on chromosome 22 to an ETS family gene, which is most commonly either FLI1 (Friend Leukemia Insertion) located on chromosome 11, t(11;22) or ERG located on chromosome 21, t(21;22).”
BackgroundSelf-citationKoelsche, C., Hartmann, W., Schrimpf, D., Stichel, D., Jabar, S., Ranft, A., Reuß, D., Sahm, F., Jones, D., Bewerunge‐Hudler, M., et al. (2018) · Modern Pathology · doi:10.1038/s41379-018-0045-3 · Cited by 111
“and 5–10 % of all cases, respectively [3, 4].”
BackgroundChromosome translocation based on illegitimate recombination in human tumors
Zucman-Rossi, J., Legoix, P., Victor, J.-M., Lopez, B., & Thomas, G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11786 · Cited by 111
Self-citationThe Expression of ccn3(nov) Gene in Musculoskeletal Tumors
Manara, M. C., Perbal, B., Benini, S., Strammiello, R., Cerisano, V., Perdichizzi, S., Serra, M., Astolfi, A., Bertoni, F., Alami, J., et al. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64908-5 · Cited by 127
The role of cytogenetics in the classification of soft tissue tumours
Tos, A. P. D., & Cin, P. D. (1997) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280050073 · Cited by 111
“The central karyotypic anomaly is a t(11;22) [3, 28 , 105] with two other variants found in some cases of Ewing sarcoma: a t(21;22) [99] and a t(7;22) [52, 100], and a der(16)t(1;16) [77] as a secondary change.”
BackgroundMélet, F., Motro, B., Rossi, D. J., Zhang, L., & Bernstein, A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.6.2708 · Cited by 112
“Manyetsfamily genes, including c-ets-1,c-ets-2,Fli-1 (Friend leukemia integration site 1), erg-1, Spi-1, and tel, also participateinoncogenicprocesseswhenactivatedasaresultof chromosomal translocations or proviral insertions (3, 8 , 11, 39).”
BackgroundSpi-1/PU.1: an oncogene of the Ets family
Moreau-Gachelin, F. (1994) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(94)90011-6 · Cited by 110
Role of FET proteins in neurodegenerative disorders
Svetoni, F., Frisone, P., & Paronetto, M. P. (2016) · RNA Biology · doi:10.1080/15476286.2016.1211225 · Cited by 115
“FET proteins are involved in sarcoma translocations that give rise to in frame fusion proteins comprising the N-terminal part of a FET protein and a transcription factor belonging to the ETS family at the carboxy-terminus.(15,16) These aberrant chimeras are potent transcription factors that guide oncogenic transformat…”
BackgroundÅman, P. (1999) · Seminars in Cancer Biology · doi:10.1006/scbi.1999.0130 · Cited by 117
Sensitive detection of occult Ewing's cells by the reverse transcriptase-polymerase chain reaction
Peter, M., Magdelénat, H., Michon, J. M., Melot, T., Oberlin, O., Jm, Z., Thomas, G. D., & Delattre, O. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.283 · Cited by 110
Self-citationSorensen, P. H. B., Shimada, H., Liu, X. F., Lim, J. F., Thomas, G. D., & Triche, T. J. (1995) · PubMed · Cited by 119
Self-citationThe Role of Ets Transcription Factors in the Development and Function of the Mammalian Immune System
Bassuk, A. G., & Leiden, J. M. (1997) · Advances in immunology · doi:10.1016/s0065-2776(08)60887-1 · Cited by 125
EWSR1 is fused to POU5F1 in a bone tumor with translocation t(6;22)(p21;q12)
Yamaguchi, S., Yamazaki, Y., Ishikawa, Y., Kawaguchi, N., Mukai, H., & Nakamura, T. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20171 · Cited by 109
“The EWSR1 gene, originally identified at the chromosome 22q12 breakpoint of Ewing sarcoma (Delattre et al., 1992), has been found to be fused to a number of other genes, leading to various types of BST (reviewed by Arvand and Denny, 2001).”
BackgroundZhang, D., Paley, A. J., & Childs, G. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18086 · Cited by 126
EWS/FLI Alters 5′-Splice Site Selection
Knoop, L. L., & Baker, S. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008950200 · Cited by 120
Nishimori, H., Sasaki, Y., Yoshida, K., Irifune, H., Zembutsu, H., Tanaka, T., Aoyama, T., Hosaka, T., Kawaguchi, S., Wada, T., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1206025 · Cited by 122
“However, EFTs are characterized by specific balanced chromosomal translocations that result in fusion of the N-terminus of the EWS gene product to the C-terminus of an ETS transcription factor including FLI1, ERG, ETV1, E1AF or FEV (Delattre et al., 1992, 1994; Sorensen et al., 1994; Giovannini et al., 1994; Jeon et a…”
BackgroundIdentification of Ewing’s sarcoma protein as a G‐quadruplex DNA‐ and RNA‐binding protein
Takahama, K., Kino, K., Arai, S., Kurokawa, R., & Oyoshi, T. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08020.x · Cited by 118
Sümegi, J., Nishio, J., Nelson, M., Frayer, R. W., Perry, D. A., & Bridge, J. A. (2010) · Modern Pathology · doi:10.1038/modpathol.2010.201 · Cited by 111
“9 that fuse the EWSR1 gene (22q12) to a subset of ETS- transcription factor gene family members, most commonly FLI1 (11q24”
BackgroundMobley, B. C., Roulston, D., Shah, G. V., Bijwaard, K. E., & McKeever, P. E. (2006) · Human Pathology · doi:10.1016/j.humpath.2006.02.011 · Cited by 110
“This translocation fuses the amino terminal–encoding portion of the EWS gene to the carboxylterminal DNA-binding domain encoded by the FLI1 gene, a member of the ETS oncogene family of DNA-binding proteins [11].”
BackgroundPlougastel-Douglas, B., Zucman‐Rossi, J., Peter, M., Thomas, G. D., & Delattre, O. (1993) · Genomics · doi:10.1016/s0888-7543(05)80363-5 · Cited by 108
Self-citationAndreoli, J. M., Jang, S. I., Chung, E., Coticchia, C. M., Steinert, P. M., & Markova, N. G. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.21.4287 · Cited by 115
Fagnou, C., Michon, J. M., Peter, M., Bernoux, A., Oberlin, O., Zucker, J. M., Magdelénat, H., & Delattre, O. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.5.1707 · Cited by 108
Self-citationSurdez, D., Zaïdi, S., Grossetête, S., Laud-Duval, K., Ferre, A. S., Mous, L., Vourc’h, T., Tirode, F., Pierron, G., Raynal, V., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.04.001 · Cited by 112
Self-citationMateo‐Lozano, S., Tirado, Ò. M., & Notario, V. (2003) · Oncogene · doi:10.1038/sj.onc.1207081 · Cited by 106
“Breakpoints of type 1 (exon 7 of EWS/exon 6 of FLI-1), type 2 (exon 7 of EWS/exon 5 of FLI-1) and type 3 (exon 10 of EWS/exon 6 of FLI-1) (Delattre et al., 1992) are most commonly detected in patients (Zucman et al., 1993).”
BackgroundKennedy, A. L., Vallurupalli, M., Chen, L., Crompton, B. D., Cowley, G. S., Vázquez, F., Weir, B. A., Tsherniak, A., Parasuraman, S., Kim, S., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4903 · Cited by 115
“The primary known oncogenic event in Ewing sarcoma is a somatic chromosomal translocation, most commonly between chromosomes 11 and 22, which results in a fusion between the 5′ region of the EWS gene and the 3′ region of the ETS family gene, FLI1 [3].”
BackgroundMolecular Diagnosis of Sarcomas: Chromosomal Translocations in Sarcomas
Lazar, A. J., Abruzzo, L. V., Pollock, R. E., Lee, S., & Czerniak, B. A. (2006) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2006-130-1199-mdos · Cited by 105
Efficacy of siRNA Nanocapsules Targeted Against the EWS–Fli1 Oncogene in Ewing Sarcoma
Toub, N., Bertrand, J., Tamaddon, A. M., Elhamess, H., Hillaireau, H., Maksimenko, A., Maccario, J., Malvy, C., Fattal, E., & Couvreur, P. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9901-9 · Cited by 115
“The EWSYFli1 fusion gene, a product of the translocation t(11;22) (q24;q12), is detected in 90% of Ewing sarcomas and primitive neuroectodermal tumors (PNETs) (3).”
BackgroundGenomic structure of the human RBP56/hTAF68 and FUS/TLS genes
Morohoshi, F., Ootsuka, Y., Arai, K., Ichikawa, H., Mitani, S., Munakata, N., & Ohki, M. (1998) · Gene · doi:10.1016/s0378-1119(98)00463-6 · Cited by 105
SLFN11 Is a Transcriptional Target of EWS-FLI1 and a Determinant of Drug Response in Ewing Sarcoma
Tang, S.-W., Bilke, S., Cao, L., Murai, J., Sousa, F. G., Yamade, M., Rajapakse, V., Varma, S., Helman, L. J., Khan, J., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2112 · Cited by 103
“Approximately 85% of ES are characterized by the chromosome translocation (11;22)(q24;q12) encoding the chimeric transcription factor EWS-FLI1 comprising the amino-terminal transactivation domain of EWSR1 fused to the carboxyterminal ETS DNA binding domain of FLI1 (11).”
Tamir, A., Howard, J., Higgins, R. R., Li, Y.-J., Berger, L., Zacksenhaus, E., Reis, M., & Ben-David, Y. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.6.4452 · Cited by 104
“Interestingly, Fli-1 is also activated in Ewing’s sarcoma as the result of a chromosomal translocation that creates a novel fusion protein in which the DNA-binding domain of Fli-1 is fused to a putative RNAbinding protein (EWS) from chromosome 22 (9).”
BackgroundThe transcription factor Spi-1/PU.1 binds RNA and interferes with the RNA-binding protein p54nrb
Hallier, M., Tavitian, A., & Moreau-Gachelin, F. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.19.11177 · Cited by 104
Solution structure of the ets domain of Fli-1 when bound to DNA
Liang, H., Mao, X., Olejniczak, E. T., Nettesheim, D. G., Yu, L., Meadows, R. P., Thompson, C. B., & Fesik, S. W. (1994) · Nature Structural & Molecular Biology · doi:10.1038/nsb1294-871 · Cited by 104
Lee, J.-H., Nguyen, P. T., Shim, H. S., Hyeon, S. J., Im, H., Choi, M., Chung, S., Kowall, N. W., Lee, S. B., & Ryu, H. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.10.042 · Cited by 111
“In 1992, Ewing sarcoma breakpoint region 1 (EWSR1)/EWS (herein termed EWSR1) gene was identified at chromosomal breakpoint t(11;22)(q24;q12) region from EWS and neuroectodermal tumors as a translocation-generated fusion gene between EWSR1 and FLI1 (Friend leukemia integration 1) [2].”
Background
Metadata
- Authors
- Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., de Jong, P., Rouleau, G., Aurias, A., & Thomas, G.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Venue
- Nature
- Published
- 1992-09
- Volume
- 359
- Issue
- 6391
- Pages
- 162-165
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2069351898
- Cited by
- 1,907
- References
- 30
- Citations by year
- 2026: 57 · 2025: 72 · 2024: 69 · 2023: 64 · 2022: 78 · 2021: 83 · 2020: 80 · 2019: 69 · 2018: 54 · 2017: 57 · 2016: 71 · 2015: 62 · 2014: 61 · 2013: 63 · 2012: 45
- FWCI
- 60.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- Ewing sarcoma, primitive neuroectodermal tumor, 22)(q24, EWSR1, gene fusion, chromosomal translocation, RNA-binding domain
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Chromosomes, Human, Pair 11, Chromosomes, Human, Pair 22, Cloning, Molecular, Gene Frequency, Humans, Molecular Sequence Data, Nucleic Acid Hybridization, Sarcoma, Ewing, Sequence Homology, Nucleic Acid, Transcription, Genetic, Translocation, Genetic, Restriction Mapping, DNA Probes, Polymerase Chain Reaction, Open Reading Frames, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.